<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.9.1" -->
<rss version="0.92">
<channel>
	<title>StemCells Therapy</title>
	<link>http://www.stemcellstherapy.tv</link>
	<description>Stem Cells Therapy and Stem Cell Research</description>
	<lastBuildDate>Thu, 11 Mar 2010 08:14:18 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Genetic Variant Raises Lung Cancer Risk</title>
		<description><![CDATA[It doesn&#8217;t matter whether you smoke a little or a lot, study finds
Source: HealthDay
Related MedlinePlus Pages: Genes and Gene Therapy, Lung Cancer, Secondhand Smoke (Source: MedlinePlus Health News)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed &#8211;  updated hourly from thousands of authoritative health and news [...]]]></description>
		<link>http://www.stemcellstherapy.tv/genetic-variant-raises-lung-cancer-risk/</link>
			</item>
	<item>
		<title>Novel stroke treatment passes safety stage of clinical trial</title>
		<description><![CDATA[A clinical research trial of a new treatment to restore brain cells damaged by stroke has passed an important safety stage, according to the neurologist who led the effort.
]]></description>
		<link>http://www.stemcellstherapy.tv/novel-stroke-treatment-passes-safety-stage-of-clinical-trial/</link>
			</item>
	<item>
		<title>FDA clears Oculus Innovative Sciences&#8217; Microcyn Skin and Wound HydroGel</title>
		<description><![CDATA[Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
]]></description>
		<link>http://www.stemcellstherapy.tv/fda-clears-oculus-innovative-sciences-microcyn-skin-and-wound-hydrogel/</link>
			</item>
	<item>
		<title>Health Care REIT prices 3.00% Convertible Senior Notes due 2029</title>
		<description><![CDATA[Health Care REIT, Inc. today announced the pricing of its offering of $342,394,000 aggregate principal amount of 3.00% Convertible Senior Notes due 2029.
]]></description>
		<link>http://www.stemcellstherapy.tv/health-care-reit-prices-3-00-convertible-senior-notes-due-2029/</link>
			</item>
	<item>
		<title>NeoPharm seeks Orphan Drug Designation for IL13-PE38QQR in treatment of IPF</title>
		<description><![CDATA[NeoPharm, Inc., announced today that it has filed an orphan drug application with the Office of Orphan Products Development of the United States Food and Drug Administration to have Orphan Drug Designation granted to IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis.
]]></description>
		<link>http://www.stemcellstherapy.tv/neopharm-seeks-orphan-drug-designation-for-il13-pe38qqr-in-treatment-of-ipf/</link>
			</item>
	<item>
		<title>Stason Pharmaceuticals to market Unilife&#8217;s Unitract 1mL safety syringe in Japan, China and Taiwan</title>
		<description><![CDATA[Unilife Corporation today announced that it has signed an exclusive five-year agreement with Stason Pharmaceuticals Inc, a U.S.-based pharmaceutical company, to market the Unitract™ 1mL safety syringe in Japan, China and Taiwan. Stason&#8217;s Taiwan-based strategic alliance affiliate, Standard Chem. and Pharm. Co., LTD, will act as the primary distributor of the product within these designated [...]]]></description>
		<link>http://www.stemcellstherapy.tv/stason-pharmaceuticals-to-market-unilifes-unitract-1ml-safety-syringe-in-japan-china-and-taiwan/</link>
			</item>
	<item>
		<title>BioTime&#8217;s fourth-quarter fiscal 2009 total quarterly revenue up 163%</title>
		<description><![CDATA[BioTime, Inc. today reported financial results for the fourth quarter and fiscal year ended December 31, 2009 and provided an update on recent corporate developments.
]]></description>
		<link>http://www.stemcellstherapy.tv/biotimes-fourth-quarter-fiscal-2009-total-quarterly-revenue-up-163/</link>
			</item>
	<item>
		<title>Affymax initiates Phase 3 clinical testing of Hematide in Japan, receives $5M milestone payment</title>
		<description><![CDATA[Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies’ exclusive global agreement to develop and commercialize Hematide™, Affymax’s investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical [...]]]></description>
		<link>http://www.stemcellstherapy.tv/affymax-initiates-phase-3-clinical-testing-of-hematide-in-japan-receives-5m-milestone-payment/</link>
			</item>
	<item>
		<title>Advances in back care and treatment options for slipped disc, spine surgery and vertebral fractures</title>
		<description><![CDATA[Approximately 21 million visits were made to physicians&#8217; offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions -including injury, herniated discs and the deterioration of the vertebrae. Three new studies presented at the 2010 Annual Meeting of the American Academy of [...]]]></description>
		<link>http://www.stemcellstherapy.tv/advances-in-back-care-and-treatment-options-for-slipped-disc-spine-surgery-and-vertebral-fractures/</link>
			</item>
	<item>
		<title>Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures</title>
		<description><![CDATA[Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
]]></description>
		<link>http://www.stemcellstherapy.tv/long-term-use-of-bisphosphonates-may-adversely-affect-bone-quality-and-increase-risk-of-atypical-fractures/</link>
			</item>
	<item>
		<title>Accelr8 Technology to present results of culture-free, quantitative pathogen identification study at 110th ASM</title>
		<description><![CDATA[Accelr8 Technology Corporation today announced that it has received acceptance to present results for a study on 2-hour, culture-free, quantitative pathogen identification. The study was co-authored with principal investigators at the Denver Health Medical Center and the Barnes-Jewish Hospital in St. Louis.
]]></description>
		<link>http://www.stemcellstherapy.tv/accelr8-technology-to-present-results-of-culture-free-quantitative-pathogen-identification-study-at-110th-asm/</link>
			</item>
	<item>
		<title>ZixCorp renewes and expandes contract with Wake Forest University Baptist Medical Center</title>
		<description><![CDATA[Zix Corporation, the only email encryption service designed with your most important relationships in mind, has renewed and expanded its contract with Wake Forest University Baptist Medical Center, a leading North Carolina health system.
]]></description>
		<link>http://www.stemcellstherapy.tv/zixcorp-renewes-and-expandes-contract-with-wake-forest-university-baptist-medical-center/</link>
			</item>
	<item>
		<title>Google CEO Eric Schmidt struck by explosion in mobile computing, defends company’s influence</title>
		<description><![CDATA[more images
more images
Google CEO: mobile computing reshaping Internet
ABU DHABI, United Arab Emirates — Google&#8217;s CEO says mobile smartphones are transforming the Internet, and defended his company&#8217;s growing dominance over information on the Web.
Eric Schmidt told an Arab media conference Wednesday he has been &#8220;struck by the explosion of mobile computing&#8221; and says the devices are [...]]]></description>
		<link>http://www.stemcellstherapy.tv/google-ceo-eric-schmidt-struck-by-explosion-in-mobile-computing-defends-company%e2%80%99s-influence/</link>
			</item>
	<item>
		<title>Ford India To Relaunch Fiesta?</title>
		<description><![CDATA[more images
NEW DELHI, INDIA (GaeaTimes.com)- Ford India seems to be on an expansion overdrive. Barely a month after opening a lot of new dealerships across India the company launched its much hyped small car Figo in the Indian market. Not only that, the auto industry experts are of the opinion that it may launch a [...]]]></description>
		<link>http://www.stemcellstherapy.tv/ford-india-to-relaunch-fiesta/</link>
			</item>
	<item>
		<title>Ford Figo Makes Its Entry</title>
		<description><![CDATA[more images
more images
NEW DELHI, INDIA (GaeaTimes.com)- Competition in the small car segment in India is becoming more intense with time. In order to grab a pie of the compact car segment which has been dominated by leading carmaker Maruti Suzuki, international carmakers are entering the market. 2010 has witnessed the launch of some exciting small [...]]]></description>
		<link>http://www.stemcellstherapy.tv/ford-figo-makes-its-entry/</link>
			</item>
	<item>
		<title>China Mobile invests $5.8B for 20 pct stake in Shanghai Pudong Bank to develop mobile banking</title>
		<description><![CDATA[China Mobile investing $5.8B in Chinese bank
HONG KONG — China Mobile Ltd., the world&#8217;s biggest phone company by subscribers, said Wednesday it was investing $5.8 billion in a Chinese bank as part of a plan to develop mobile phone banking and business services.
Under the agreement, China Mobile will pay 39.8 billion yuan ($5.8 billion) in [...]]]></description>
		<link>http://www.stemcellstherapy.tv/china-mobile-invests-5-8b-for-20-pct-stake-in-shanghai-pudong-bank-to-develop-mobile-banking/</link>
			</item>
	<item>
		<title>Model may offer better understanding of embryonic development</title>
		<description><![CDATA[A mathematical model developed at Purdue University can predict complex signaling patterns that could help scientists determine how stem cells in an embryo later become specific tissues, knowledge that could be used to understand and treat developmental disorders and some diseases.  (2010-03-10)
]]></description>
		<link>http://www.stemcellstherapy.tv/model-may-offer-better-understanding-of-embryonic-development/</link>
			</item>
	<item>
		<title>Limb of huge ‘botnet’ of virus-infected PCs is amputated, but criminals are reconnecting</title>
		<description><![CDATA[Huge &#8216;botnet&#8217; amputated, but criminals reconnect
SAN JOSE, Calif. — The sudden takedown of an Internet provider helping spread a promiscuous piece of malicious software has cut off criminals from possibly millions of personal computers under their control.
But it appears to have been short-lived.
Less than a day after the service was unplugged from the Internet, security [...]]]></description>
		<link>http://www.stemcellstherapy.tv/limb-of-huge-%e2%80%98botnet%e2%80%99-of-virus-infected-pcs-is-amputated-but-criminals-are-reconnecting/</link>
			</item>
	<item>
		<title>CA to buy Nimsoft Inc. for $350 million in cash, expands reach into smaller companies</title>
		<description><![CDATA[CA to buy Nimsoft Inc. for $350 million in cash
ISLANDIA, N.Y. — Technology management software company CA Inc. said Wednesday that it&#8217;s buying Nimsoft Inc. for $350 million in cash.
The acquisition gives CA a cadre of smaller-company clients served by Nimsoft whose revenues typically run from $300 million to $2 billion. CA historically has focused [...]]]></description>
		<link>http://www.stemcellstherapy.tv/ca-to-buy-nimsoft-inc-for-350-million-in-cash-expands-reach-into-smaller-companies/</link>
			</item>
	<item>
		<title>Summary Box: Review of Google’s social hub, Buzz</title>
		<description><![CDATA[more images
more images
Summary Box: Review of Google&#8217;s social hub, Buzz
THE BUZZ: Google&#8217;s answer to the popularity of social networking. Circles of friends can connect right on Google&#8217;s Gmail home page.
THE CIRCLES: Many circles have been automatically created based on frequency of past e-mail contact. As a result, users don&#8217;t have the same vested interest in [...]]]></description>
		<link>http://www.stemcellstherapy.tv/summary-box-review-of-google%e2%80%99s-social-hub-buzz/</link>
			</item>
</channel>
</rss>
